Vaccines Delivered On Time Across Australia For Largest National Immunisation Program On Record

For immediate release
October 6, 2009

Vaccines delivered on time across Australia for largest
national immunisation program on record

CSL Biotherapies, a subsidiary of CSL - Australia's leading biopharmaceutical
company, can today confirm that 100% of deliveries of its H1N1 influenza
vaccine are being completed on time in all States.

As the H1N1 2009 pandemic vaccination program is the biggest of its kind ever
to be rolled out in Australia, CSL committed to complete all initial orders for
vaccine within 10 working days. As of September 30, 97.4% of all initial order
deliveries were completed within 5 days, and 100% of deliveries completed
nationally within 6 days.

As the only manufacturer of influenza vaccines in the Southern Hemisphere,
CSL has been working for close to four decades with the Federal Government
and State Health Departments to provide and distribute seasonal influenza
vaccines for all Australians on an annual basis. This knowledge and experience
has enabled CSL to respond rapidly to the pandemic threat posed by the H1N1
(2009) influenza or 'swine flu' virus, through the manufacture, registration and
distribution of its vaccine in record time.

With the H1N1 (2009) national vaccination program commencing on September
30, CSL has taken seriously its responsibility to provide a vaccine against this
pandemic as quickly as possible. CSL has ensured that deliveries to groups
considered `at risk' have been given priority. All regional health districts
designated `high risk' were supplied vaccine on the launch date in order to
ensure that immunisation could commence for these identified groups, as well
as health care workers.

"Our H1N1 vaccine delivery times exceeded our expectations, as CSL has been
able to fulfil vaccine orders in virtually half the expected period." Mary Sontrop,
General Manager of CSL Biotherapies, said today.


Page 2 October 6, 2009


"CSL has been able to provide such an excellent service level of distribution
response due to its unique TGA approved cold-chain distribution network across
Australia. This coupled with the support and commitment from CSL's supply
chain staff, and drawing on our existing relationships with our quality approved
carriers and state immunisation coordinators, has ensured the initial distribution
of vaccine for the program has been rolled out expeditiously" she said.

To date, CSL has delivered in excess of 2 million doses of vaccine across the
country, and has more than 3 million doses across CSL's interstate warehouse
network ready to ship to immunisation providers upon receipt of an order.


For more information about CSL Limited, visit www.csl.com.au


Media Contacts
Australia and New Zealand
Dr Rachel David
Director of Public Affairs
CSL Limited
(Ph:) +61 3 9389 1821
[email protected]